Severe persistent visual field constriction associated with vigabatrin

British Medical Journal

Volumn 314, Issue 7075, 1997, Pages 180-181

  Eke, T ^a   Talbot, J F ^b   Lawden, M C ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOCAL EPILEPSY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; PIGMENT EPITHELIUM; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; VISUAL FIELD DEFECT;

EID: 0031015788     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7075.180     Document Type: Article

References (5)

1. Marion Merrell Dow Pharmaceuticals. Data sheet for Sabril (vigabatrin). In: Walker G, ed. ABPI data sheet compendium 1995-96. London: Datapharm Publications:956-7.
2. Dieterle L, Becker EW, Berg PA, Berkenfeld R, Reinshagen G. Allergische Vaskulitis durch Vigabatrin. Nervenarzt 1994;65:122-4.
3. Faedda MT, Giallonardo AT, Marchetti A, Manfredi M. Terapia con vigabatrin nelle epilessie parziali resistenti. G Neuropsicofarmacol 1993;15:105-8.
4. Graham D. Neuropathology of vigabatrin. Br J Clin Pharmacol 1989;27(suppl 1):43-5S.
5. Butler WH, Ford GP, Newberne JW. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Toxicologic Pathology 1987;15:143-8.